Alavar, Ruby Jane .

HRN: 26-04-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFUROXIME 1.5GM (VIAL)
01/23/2025
01/23/2025
IV
1.5g
PTOR ANST
Cs
Waiting Final Action 
01/23/2025
CEFUROXIME 1.5GM (VIAL)
01/23/2025
01/24/2025
IV
1.5 G
Q8 X 3 Doses
Sp Repeat LTCS
Waiting Final Action 
01/23/2025
CEFUROXIME 500MG (TAB)
01/25/2025
01/31/2025
PO
500 Mg
BID
Sp Repeat LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: